help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fruehwald-Schultes, B.
Right arrow Articles by Peters, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fruehwald-Schultes, B.
Right arrow Articles by Peters, A.
The Journal of Clinical Endocrinology & Metabolism Vol. 84, No. 5 1551-1557
Copyright © 1999 by The Endocrine Society


Original Studies

Protective Effect of Insulin against Hypoglycemia-Associated Counterregulatory Failure

Bernd Fruehwald-Schultes, Werner Kern, Eva Deininger, Peter Wellhoener, Wolfgang Kerner, Jan Born, Horst L. Fehm and Achim Peters

Departments of Internal Medicine I (B.F.-S., W.K., W.B., P.W., H.L.F., A.P.) and Clinical Neuroendocrinology (J.B.), University of Luebeck, D-23538 Luebeck, and the Department of Diabetes and Metabolism, Klinikum Karlsburg (W.K.), D-17495 Karlsburg, Germany

Address all correspondence and requests for reprints to: Bernd Fruehwald-Schultes, M.D., Medical University Luebeck, Department of Internal Medicine I, Ratzeburger Allee 160, D-23538 Luebeck, Germany. E-mail: fruehwal{at}kfg.mu-luebeck.de

Antecedent hypoglycemic episodes reduce the counterregulatory neuroendocrine response to hypoglycemia. The role of insulin in the mechanism responsible for the antecedent hypoglycemia causing subsequent counterregulatory failure has not been elucidated. We performed antecedent hypoglycemic clamps (56 mg/dL) lasting 2 h with differing degrees of hyperinsulinemia, which were followed by 6-h stepwise hypoglycemic clamps (76–66–56–46 mg/dL) on the next day. Experiments were carried out in 30 young, healthy men. Fifteen of these subjects were tested on 2 occasions. On 1 occasion the antecedent hypoglycemia was induced by insulin infusion at a rate of 1.5 mU/min·kg (low insulin-ante-hypo); on the other occasion the insulin infusion rate was 15.0 mU/min·kg (high insulin-ante-hypo). Both sessions were separated by at least 4 weeks, and their order was balanced across subjects. The remaining 15 subjects (control group) received the same stepwise hypoglycemic clamp as the other subjects, but without antecedent hypoglycemia. During the stepwise hypoglycemic clamp, the counterregulatory increases in ACTH, cortisol, and norepinephrine were significantly blunted after the low insulin-ante-hypo (P < 0.01, P < 0.05, and P < 0.05, respectively) but not after the high insulin-ante-hypo (P = 0.12, P = 0.92, and P = 0.19, respectively) compared to that in the control group. The cortisol, norepinephrine, and glucagon responses were greater after the high than after the low insulin-ante-hypo (all P < 0.05). In conclusion, the present study clearly demonstrates that even a single episode of mild hypoglycemia reduces neuroendocrine counterregulation 18–24 h later. Insulin has a moderate protective effect on subsequent counterregulation.




This article has been cited by other articles:


Home page
DiabetesHome page
D. A. Sandoval, L. Ping, A. R. Neill, S. Morrey, and S. N. Davis
Cortisol Acts Through Central Mechanisms to Blunt Counterregulatory Responses to Hypoglycemia in Conscious Rats
Diabetes, September 1, 2003; 52(9): 2198 - 2204.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Schultes, K. M. Oltmanns, W. Kern, H. L. Fehm, J. Born, and A. Peters
Modulation of Hunger by Plasma Glucose and Metformin
J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1133 - 1141.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
E. M. Bingham, D. Hopkins, D. Smith, A. Pernet, W. Hallett, L. Reed, P. K. Marsden, and S. A. Amiel
The Role of Insulin in Human Brain Glucose Metabolism: An 18Fluoro-Deoxyglucose Positron Emission Tomography Study
Diabetes, December 1, 2002; 51(12): 3384 - 3390.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Fruehwald-Schultes, W. Kern, K. M. Oltmanns, S. Sopke, B. Toschek, J. Born, H. L. Fehm, and A. Peters
Metformin Does Not Adversely Affect Hormonal and Symptomatic Responses to Recurrent Hypoglycemia
J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4187 - 4192.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Fruehwald-Schultes, W. Kern, W. Bong, P. Wellhoener, W. Kerner, J. Born, H. L. Fehm, and A. Peters
Supraphysiological Hyperinsulinemia Acutely Increases Hypothalamic-Pituitary-Adrenal Secretory Activity in Humans
J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3041 - 3046.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1999 by The Endocrine Society